A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma.

Martin Eatock

Research output: Contribution to journalArticle

54 Citations (Scopus)
Original languageEnglish
Pages (from-to)435-441
Number of pages7
JournalCancer Chemotherapy and Pharmacology
Volume61(3)
Issue number3
DOIs
Publication statusPublished - Mar 2008

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Oncology

Cite this